Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.
通过创新的基于 cVLP 的疫苗靶向 PCSK9,增强了 cVLP-HER2 疫苗在 HER2 阳性乳腺癌临床前模型中的治疗活性
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06126-w
Scalambra Laura, Ruzzi Francesca, Pittino Olga Maria, Semprini Maria Sofia, Cappello Chiara, Angelicola Stefania, Palladini Arianna, Nanni Patrizia, Goksøyr Louise, Fougeroux Cyrielle, Penichet Manuel L, Sander Adam Frederik, Lollini Pier-Luigi